Purchase Order 75N94025P00315

Award Date 9/14/25
Potential Completion Date 9/13/26
Potential Value $50K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), which is part of the U.S. Department of Health and Human Services, to Gardner Pharmacology LLC, a woman-owned small business. The $50,000.00 contract is for pharmacology consulting services, including pre-clinical and clinical pharmacology consulting, expert consultation on ethical, policy, and regulatory issues related to contraceptive research and product development,...
The National Institute of Child Health and Human Development (NICHD), a civilian agency within the Department of Health and Human Services, awarded a $25,000.00 firm-fixed-price purchase order to Gardner Pharmacology LLC, a woman-owned small business, for pharmacology consulting services. The contract does not have a set-aside designation. The services provided under this award include pre-clinical and clinical pharmacology consulting, expert consultation on ethical, policy, and regulatory...
The National Institute of Child Health and Human Development (NICHD), a civilian agency within the Department of Health and Human Services, awarded a $24,872.40 firm fixed-price purchase order to Gardner Pharmacology LLC, a woman-owned small business, for pharmacology consulting services related to the institute's contraception research programs. The services include providing expert consultation on pre-clinical and clinical pharmacology, ethical and regulatory issues, and other specialized...
Gardner Pharmacology LLC has been awarded a $50,000 firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health National Institute of Child Health and Human Development to provide pharmacology consulting services. The contract calls for the contractor to deliver pre-clinical and clinical pharmacology consulting, as well as expert consultation on ethical, policy, and regulatory issues related to the agency's contraceptive research portfolio and...
The National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, awarded a $20,000.00 firm fixed price purchase order contract to Leadingedge Pharmtox, LLC, a self-certified small disadvantaged business, for toxicology consulting services related to reproductive science and health. The contract, which was set aside for small businesses, has an ultimate completion date of August 24, 2025. Leadingedge Pharmtox, LLC...
This federal contract award, valued at $25,000.00, was made by the National Institute of Child Health and Human Development (NICHD) to Leadingedge Pharmtox, LLC, a small disadvantaged business, to provide toxicology consulting services related to reproductive science and health. The contract, which was not set aside, involves reviewing, monitoring, and reporting on the safety of NICHD-funded research projects focused on reproduction, development, and potential health impacts. Leadingedge...
This is a $72,074.71 cost-no-fee delivery order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services. The order tasks Essential Access Health, a non-profit organization, to assist in the development of new contraceptive products by providing services related to protocol review, protocol development, and activities associated with the NICHD Contraceptive Clinical Trials Network. This award is...
This federal contract award from the National Institute of Child Health and Human Development (NICHD), a civilian agency, is for $2,032,799.45 to provide statistical and clinical coordinating services for a study evaluating the pharmacokinetics and pharmacodynamics of intramuscular or subcutaneous injections of levonorgestrel butanoate for female contraception. The contract was awarded to Health Decisions, Inc., a for-profit clinical research organization located in Morrisville, North...
This is a $3,170,829.13 firm-fixed-price delivery order contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Health Decisions, Inc., a for-profit clinical research organization located in Morrisville, North Carolina. The contract is for the evaluation of the pharmacokinetic profile, effects on the mechanisms of contraceptive efficacy, and safety of multipurpose prevention technologies products. This contract is part of the Statistical...
This is a $535,124 firm-fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the National Institutes of Health (NIH), to the Public Health Institute (PHI), a non-profit organization. The contract is for "NICHD SERVICES: MPT DATABASE ACCESS AND MAINTENANCE" and "NICHD SERVICES: MPT DATABASE ACCESS AND MAINTENANCE - SEVERABLE" with a period of performance from September 27, 2023 through September...

This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a division of the U.S. Department of Health and Human Services, to Gardner Pharmacology LLC, a woman-owned small business located in Vienna, Virginia. The $50,000.00 contract is for pharmacology consulting services to support NICHD's Contraception Research Branch, providing expert pre-clinical and clinical pharmacology consultation, as well as guidance on ethical, policy, and regulatory issues related to contraceptive research and product development. The contract has a base period of one year from September 1, 2025 to August 31, 2026. This non-competitive procurement was conducted under FAR Part 13 Simplified Acquisition Procedures and did not utilize any set-aside designations.

Generated 6/27/25, 12:17 PM